2020
DOI: 10.1007/s10072-020-04286-9
|View full text |Cite
|
Sign up to set email alerts
|

The effect of greater occipital nerve blockade on the quality of life, disability and comorbid depression, anxiety, and sleep disturbance in patients with chronic migraine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 29 publications
3
13
0
Order By: Relevance
“…Thirteen open-label studies 29,[32][33][34][35][36][37][38][39][40][41][42][43] and 10 placebo-controlled trials [44][45][46][47][48][49][50][51][52][53] were read in detail. Of these, nine open-label studies 29,[34][35][36][38][39][40][41]43 and four placebo-controlled studies [47][48][49][50] were found suitable for the present review meeting the inclusion and exclusion criteria. Four open-label 32,33,37,42 and six placebo-controlled studies [44][45][46][51][52][53] that were excluded for efficacy and safety analysis have been briefly described separately (Appendix 1) to highlight the reasons for their exclusion.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Thirteen open-label studies 29,[32][33][34][35][36][37][38][39][40][41][42][43] and 10 placebo-controlled trials [44][45][46][47][48][49][50][51][52][53] were read in detail. Of these, nine open-label studies 29,[34][35][36][38][39][40][41]43 and four placebo-controlled studies [47][48][49][50] were found suitable for the present review meeting the inclusion and exclusion criteria. Four open-label 32,33,37,42 and six placebo-controlled studies [44][45][46][51][52][53] that were excluded for efficacy and safety analysis have been briefly described separately (Appendix 1) to highlight the reasons for their exclusion.…”
Section: Resultsmentioning
confidence: 99%
“…Both the authors independently read the titles and the abstracts and excluded the articles which prima facie did not address our review question regarding the efficacy and safety of the GON block in CM. Thirteen open-label studies 29,32 43 and 10 placebo-controlled trials 44 53 were read in detail. Of these, nine open-label studies 29,34 –36,38 41,43 and four placebo-controlled studies 47 50 were found suitable for the present review meeting the inclusion and exclusion criteria.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“… 88 , 89 GONB treatment may be initially considered if comorbidities such as stress, depression and sleep disturbance are high in CM patients with few treatment options. 88 …”
Section: Evaluation Of Sleep Quality After Treatment Of Chronic Migrainementioning
confidence: 99%